Clinical Trials
12 trialsNCT04729348 2025-07-25
Pembrolizumab And Lenvatinib In Leptomeningeal Metastases
Massachusetts General Hospital
Phase 2 Terminated
NCT03661424 2022-12-20
BATs in Patients With Breast Cancer and Leptomeningeal Metastases
University of Virginia
Phase 1 Terminated
NCT02684071 2020-01-10
Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors
Nicklaus Children's Hospital f/k/a Miami Children's Hospital
Phase 2 Terminated
NCT01596127 2018-05-24
Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT00512460 2016-05-16
RTA 744 Injection in Patients With Leptomeningeal Disease
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT00964743 2013-09-09
Depocyt® With Sorafenib in Neoplastic Meningitis
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Terminated
NCT00523939 2013-06-17
DepoCyt for Active Lymphomatous or Leukemic Meningitis
Duke University
Phase 2 Terminated
NCT00005812 2013-05-14
Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma
Dartmouth-Hitchcock Medical Center
Phase 2 Terminated
NCT00074607 2012-11-12
Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine
Baylor College of Medicine
Phase 1 Terminated
NCT00477503 2012-08-01
Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT00515788 2012-03-12
DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT00830245 2011-07-26
A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer
Clinical Research Center for Solid Tumor, Korea
Phase 2 Terminated